Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.957 |
46 |
1
|
2008 |
2019 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.100 |
None |
1.000 |
33 |
|
2008 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
14 |
|
2008 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
11 |
|
2008 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1486
|
39
|
0.080 |
None |
1.000 |
8 |
|
2008 |
2018 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2018 |
Neoplasms, Intracranial
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
157
|
4
|
0.310 |
None |
1.000 |
2 |
|
2012 |
2014 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2017 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Gastrointestinal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
182
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pleural effusion disorder
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
227
|
14
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.060 |
None |
0.833 |
6 |
|
2008 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.330 |
None |
1.000 |
5 |
|
2012 |
2019 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.030 |
None |
1.000 |
3 |
|
2008 |
2018 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adenocarcinoma in Situ
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
55
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Lymphadenopathy
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
277
|
5
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary Lesion
|
phenotype |
|
Disease or Syndrome
|
71
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2016 |
2016 |